Auxly Cannabis Group stock: Q3 revenue rises 24 percent
Published on 11/12/2026 at 14:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAuxly reports stronger quarterly operations
- Adjusted EBITDA rose 29 percent and the margin reached 32 percent.
- Net income declined because the prior-year quarter included a settlement gain.
- Auxly plans up to CAD 30 million of capital investment through 2028.
Auxly Cannabis Group released its results for the three and nine months ended September 30, 2026, on Thursday, November 12. According to the company release published by PR Newswire, net revenue increased 24 percent year over year to CAD 49.5 million.
Adjusted EBITDA advanced 29 percent to CAD 15.8 million, producing a 32 percent margin. The gross margin on finished cannabis inventory sold held at 56 percent, while cash flow from operations before working capital changes rose 28 percent to CAD 14.8 million.
Profit comparison reflects prior-year gain
Net income was CAD 13.6 million, down from CAD 20.5 million in the prior-year quarter. Auxly said the 2025 figure included an after-tax gain of CAD 8.1 million from the Imperial Debenture Settlement. Excluding that gain and fair-value adjustments on biological transformation and inventory, net income increased by CAD 4.4 million, or 70 percent.
Management attributed the revenue increase to higher volumes across the core portfolio and improved flower pricing. Vape-product price compression partly offset those gains. Selling, general and administrative expenses rose in absolute terms but declined to 27.7 percent of revenue from 29.2 percent a year earlier.
Capacity investment remains central
Auxly said it expects to invest up to CAD 30 million through the end of 2028, including 2026 projects at its Leamington facility. The company expects those projects to lift production capacity by 30 percent from 2025 levels. It plans to commit CAD 10 million to CAD 12 million of operating cash flow to the projects in 2026, with part of the spending expected in the first half of 2027.
Auxly Cannabis Group stock traded at 2.25 euros on Lang & Schwarz at 14:01 CET on Thursday, November 12, 2026.
Auxly Cannabis Group Inc.
- ISIN: CA05335P7039
- Toronto ticker: XLY
- Lang & Schwarz price: 2.25 euros on November 12, 2026, at 14:01 CET
- Q3 net revenue: CAD 49.5 million
- Q3 Adjusted EBITDA: CAD 15.8 million
- Cash and cash equivalents: CAD 51.4 million as of September 30, 2026
Canadian cannabis equities remain sensitive to regulatory developments, consumer demand and access to capital. The broader market context is tracked through the S&P/TSX Composite.
Further updates are available in more news and analyses on Auxly Cannabis Group stock.
